As of 2026-05-22, the Relative Valuation of Collegium Pharmaceutical Inc (COLL) is 54.63 USD. This relative valuation is based on P/E multiples. With the latest stock price at 34.42 USD, the upside of Collegium Pharmaceutical Inc based on Relative Valuation is 58.7%.
The range of the Relative Valuation is 46.36 - 68.91 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.1x - 29.8x | 26.5x |
| Forward P/E multiples | 18.7x - 19.4x | 19.4x |
| Fair Price | 46.36 - 68.91 | 54.63 |
| Upside | 34.7% - 100.2% | 58.7% |
| Date | P/E |
| 2026-05-19 | 14.54 |
| 2026-05-18 | 14.55 |
| 2026-05-15 | 14.61 |
| 2026-05-14 | 15.06 |
| 2026-05-13 | 15.08 |
| 2026-05-12 | 15.43 |
| 2026-05-11 | 15.49 |
| 2026-05-08 | 16.35 |
| 2026-05-07 | 17.01 |
| 2026-05-06 | 15.79 |
| 2026-05-05 | 15.27 |
| 2026-05-04 | 14.95 |
| 2026-05-01 | 14.84 |
| 2026-04-30 | 14.59 |
| 2026-04-29 | 14.60 |
| 2026-04-28 | 14.19 |
| 2026-04-27 | 14.17 |
| 2026-04-24 | 14.05 |
| 2026-04-23 | 13.96 |
| 2026-04-22 | 14.30 |
| 2026-04-21 | 14.39 |
| 2026-04-20 | 14.84 |
| 2026-04-17 | 14.88 |
| 2026-04-16 | 14.29 |
| 2026-04-15 | 15.10 |
| 2026-04-14 | 15.41 |
| 2026-04-13 | 15.40 |
| 2026-04-10 | 15.34 |
| 2026-04-09 | 15.24 |
| 2026-04-08 | 14.46 |
| 2026-04-07 | 14.17 |
| 2026-04-06 | 14.09 |
| 2026-04-02 | 13.97 |
| 2026-04-01 | 14.38 |
| 2026-03-31 | 14.30 |
| 2026-03-30 | 13.83 |
| 2026-03-27 | 14.03 |
| 2026-03-26 | 14.45 |
| 2026-03-25 | 14.38 |
| 2026-03-24 | 14.37 |
| 2026-03-23 | 15.02 |
| 2026-03-20 | 15.33 |
| 2026-03-19 | 15.70 |
| 2026-03-18 | 15.05 |
| 2026-03-17 | 15.45 |
| 2026-03-16 | 15.40 |
| 2026-03-13 | 14.92 |
| 2026-03-12 | 15.13 |
| 2026-03-11 | 15.40 |
| 2026-03-10 | 15.83 |